Liu, T., Dai, X., Xu, Y., Guan, T., Hong, L., Zaib, T., . . . Sun, P. (2023). CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma. BMC.
Chicago Style (17th ed.) CitationLiu, Tingdang, et al. CD22 Is a Potential Target of CAR-NK Cell Therapy for Esophageal Squamous Cell Carcinoma. BMC, 2023.
MLA (9th ed.) CitationLiu, Tingdang, et al. CD22 Is a Potential Target of CAR-NK Cell Therapy for Esophageal Squamous Cell Carcinoma. BMC, 2023.
Warning: These citations may not always be 100% accurate.